Semi-finished
Dabigatran Etexilate Mesylate Pellets
- Active ingredient(s)
- Dabigatran Etexilate Mesylate
- Dosage form
- Pellets
- Release profile
- Immediate release
- Formulation type
- Semi-finished
- Listed strengths
- 30%35%40%40.35%43%
- Availability
- On enquiry
For percentage strengths, discuss the assay basis, specifications and final dosage form with our technical team.
Chemistry
Molecular profile
Dabigatran Etexilate Mesylate
- Molecular formula
- C35H45N7O8S
- Molecular weight
- 723.8 g/mol
- CAS number
- 872728-81-9
- IUPAC name
- ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
Chemical data from PubChem (CID 135566083)
Product availability and regulatory status vary by market. Information is provided for qualified business, technical and regulatory enquiries only, and is not medical advice, a promotion to patients, or an offer of sale. Nothing here implies approval or registration in any particular market.
